[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
Sarepta Therapeutics, Inc. (SRPT)
Sarepta Therapeutics (SRPT) sees analyst upgrades and price target increases, with Wedbush initiating coverage at 'Outperform' and a $XX price target, signaling potential upside driven by Elevidys and its broader Duchenne portfolio.
About Sarepta Therapeutics, Inc.
Sarepta Therapeutics, Inc. is a healthcare company focused on gene therapy for rare diseases.
Sarepta Therapeutics, Inc. uses the ticker $SRPT for trading. Listed in the Stocks category within the Healthcare sectors.
Insights
- Sarepta Therapeutics, Inc. (SRPT) trading volume is up XXXXX% from the previous week.
- Sarepta Therapeutics, Inc. (SRPT) social dominance is up XXXXXX% from the previous week.
- Sarepta Therapeutics, Inc. (SRPT) posts created is up XXXXX% from the previous week.
Price: $XXXXX
Price 24-Hour Time-Series Raw Data
The stock price has seen a recent rise, potentially driven by positive FDA news regarding Elevidys and analyst price target increases, suggesting a recovery despite previous concerns. Social posts indicate a bullish sentiment with many users discussing accumulation and potential upside.
24-Hour: -XXXX% 7-Day: -XXXX% 30-Day: XXXXX%
1-Year High: $XXXXXX on 2025-01-06
1-Year Low: $XXXXX on 2025-07-25
AltRank: XXX
AltRank 24-Hour Time-Series Raw Data
Sarepta Therapeutics, Inc. (SRPT) is currently AltRank #833 based on combined combined social and market metrics
Daily Average: XXX
X Week: XXX -XXX
X Month: XXX -XXX
X Months: XXX -XXXXX
X Year: XXX +63
1-Year High: XXXXX on 2025-09-17
1-Year Low: X on 2025-07-29
Galaxy Score: XXXXX
Galaxy Score 24-Hour Time-Series Raw Data
Current Value: XXXXX
Daily Average: XX
X Week: XX -XX
X Month: XX no change
X Months: XX +10
X Year: XX -XX
1-Year High: XX on 2025-10-02
1-Year Low: XX on 2025-03-09
Engagements: XXXXXX (24h)
Engagements 24-Hour Time-Series Raw Data
Current Value: XXXXXX
Daily Average: XXXXXX
X Week: XXXXXX -XXXX%
X Month: XXXXXXX -XX%
X Months: XXXXXXXXXX +174%
X Year: XXXXXXXXXX +53%
1-Year High: XXXXXXXXX on 2025-07-18
1-Year Low: XXXXX on 2025-12-06
Engagements by network (24h): Reddit: XX TikTok: X X: XXXXXX
Mentions: XXX (24h)
Mentions 24-Hour Time-Series Raw Data
Current Value: XXX
Daily Average: XXX
X Week: XXX -XX%
X Month: XXXXX -XX%
X Months: XXXXXX +341%
X Year: XXXXXX +309%
1-Year High: XXXXX on 2025-07-18
1-Year Low: XX on 2025-01-26
Mentions by network (24h): Reddit: XX TikTok: X X: XXXXX
Creators: XXX (24h)
Creators 24-Hour Time-Series Raw Data
XXX unique social accounts have posts mentioning Sarepta Therapeutics, Inc. (SRPT) in the last XX hours which is down XXXX% from XXX in the previous XX hours
Daily Average: XXX
X Week: XXX -XXXX%
X Month: XXXXX -XXXX%
X Months: XXXXXX +949%
X Year: XXXXXX +695%
1-Year High: XXXXX on 2025-07-17
1-Year Low: XX on 2025-01-26
The most influential creators that mention Sarepta Therapeutics, Inc. in the last XX hours
| Creator | Rank | Followers | Posts | Engagements |
|---|---|---|---|---|
| @commonsenseplay | X | XXXXXX | XX | XXXXX |
| @Hall8Jack | X | XXXXX | X | XXXXX |
| @yachmod | X | XXX | X | XXXXX |
| @monaco_biotech | X | XXXXX | X | XXXXX |
| @WalterScottFund | X | XXX | X | XXX |
| @RNAiAnalyst | X | XXXXXX | X | XXX |
| @texasbricken | X | XXX | X | XXX |
| @Lycanbull | X | XXXXX | X | XXX |
| @Tickeron | X | XXXXXX | X | XXX |
| @tradingsssss | XX | XXX | X | XXX |
Sentiment: XX%
Sentiment 24-Hour Time-Series Raw Data
Current Value: XX%
Daily Average: XX%
X Week: XX% -XX%
X Month: XX% -X%
X Months: XX% +1%
X Year: XX% -XX%
1-Year High: XX% on 2025-01-27
1-Year Low: XX% on 2025-05-08
Most Supportive Themes:
- Elevidys Potential: (55%) Analysts are optimistic about Sarepta Therapeutics' potential for gene therapy, particularly Elevidys, citing potential upside and long-term value.
Most Critical Themes:
- Regulatory Concerns: (10%) Concerns about regulatory issues and market volatility following two patient deaths linked to Sarepta's gene therapy.
Social Dominance: XXXXX%
Social Dominance 24-Hour Time-Series Raw Data
Current Value: XXXXX%
Daily Average: XXXXX%
X Week: XXXXX% +0.052%
X Month: XXXXX% +0.042%
X Months: XXXXX% +0.02%
X Year: XXXXX% -XXXXX%
1-Year High: XXXXX% on 2025-07-18
1-Year Low: XXXXX% on 2025-12-06
Market Dominance: XXXXXXX%
Market Dominance 24-Hour Time-Series Raw Data
Current Value: XXXXXXX%
Daily Average: X%
1-Year High: XXXXX% on 2025-03-31
1-Year Low: XXXXXX% on 2025-07-25
Market Cap: $XXXXXXXXXXXXX
Market Cap 24-Hour Time-Series Raw Data
Current Value: $XXXXXXXXXXXXX
Daily Average: $XXXXXXXXXXXXX
X Week: $XXXXXXXXXXXXX -$4.40%
X Month: $XXXXXXXXXXXXX +$15%
X Months: $XXXXXXXXXXXXX -$39%
X Year: $XXXXXXXXXXXXX -$82%
1-Year High: $XXXXXXXXXXXXXX on 2025-01-04
1-Year Low: $XXXXXXXXXXXXX on 2025-07-25
Top Sarepta Therapeutics, Inc. Social Posts
Top posts by engagements in the last XX hours
Showing only X posts for non-authenticated requests. Use your API key in requests for full results.
"The day begins. US equity futures are leaning weak. Strength: $PL $GEMI $CIEN $U $ROKU $NVO $NFLX $AAPL Weakness: $ORCL $URG $SRPT $CRWV $BMNR $NVDA Have a good Thursday 🌥 @petenajarian - Pluribus 1x03"
X Link @Trading_Sunset 2025-12-11T13:03Z 3481 followers, XXX engagements
"$SRPT - Sarepta Therapeutics is exchanging about $XXXXX million in existing convertible notes for new notes worth approximately $XXXXX million along with $XXXX million in cash. Read more on"
X Link @visufinance 2025-12-11T12:16Z XXX followers, XXX engagements
"📋📊 $SRPT Sarepta Therapeutics Announces Refinancing of $XXXXX Million in Convertible Notes On December XX 2025 Sarepta Therapeutics Inc. #SEC #8K #Pharma #Biotech"
X Link @booooogy01 2025-12-11T12:15Z X followers, XXX engagements
"$SRPT Sarepta Therapeutics Announces Refinancing of Approximately $XXX Million of XXXX% Convertible Senior Notes due 2027 BioPharmCatalyst"
X Link @monaco_biotech 2025-12-11T12:14Z 6172 followers, 1456 engagements